Net Loss Per Share - Schedule of Antidilutive Securities Excluded From Computation of Net Loss per Share (Details) - shares |
3 Months Ended | |
|---|---|---|
Mar. 31, 2026 |
Mar. 31, 2025 |
|
| Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items] | ||
| Antidilutive securities (in shares) | 6,913,771 | 5,907,552 |
| Shares issuable upon exercise of stock options | ||
| Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items] | ||
| Antidilutive securities (in shares) | 3,123,218 | 2,265,453 |
| Shares issuable upon the exercise of warrants (excluding pre-funded warrants) | ||
| Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items] | ||
| Antidilutive securities (in shares) | 3,555,319 | 3,642,099 |
| Unvested shares under restricted stock grants | ||
| Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items] | ||
| Antidilutive securities (in shares) | 235,234 | 0 |